EUVIMEDEUVIMED entdecken
Crossref

Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3–2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis

Xiumei Zheng, Zhe Zhang, Tianhu Shan, Maozhen Zhao, Haiyan Lu, Lanwei Zhang, Xi Liang

Probiotics and Antimicrobial Proteins · 2025-12 · 17 (6) · 4851-4866

DOI: 10.1007/s12602-024-10417-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, online erschienen am 21.12.2024. Verfasst von Xiumei Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao, 266100, Shandong, China. Hauptthemen laut MEDLINE: Atherosclerosis, Methylamines, Bile Acids and Salts, Probiotics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Youth Program of Natural Science Foundation of Shandong province, Qingdao postdoctoral applied research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a major cause of cardiovascular disease (CVD). The trimethylamine (TMA)-trimethylamine N-oxide (TMAO) pathway is a key crossover pathway highly associated with diet, gut microbiome, and atherosclerosis. The Bifidobacterium animalis subsp. lactis F1-3-2 (Bif. animalis F1-3-2, No. CCTCCM2020832) was screened through in vitro and in vivo experiments in the early stage of this study with excellent lipid-lowering and anti-inflammatory function. By building an atherosclerosis model and focusing on TMAO, the specific mechanism of Bif. animalis F1-3-2 to improve atherosclerosis was explored. The study found that Bif. animalis F1-3-2 effectively improved the accumulation of aortic plaque in atherosclerotic mice. The strain improved lipid metabolism in serum and liver. It decreased the serum TMA and TMAO, regulated bile acid composition, participated in the farnesoid X receptor (FXR) pathway to improve lipid metabolism, and further reduced the aortic macrophage foam cell accumulation. In addition, the strain could improve the structure of the intestinal microbiome and reduce the proportion of Firmicutes and Bacteroidetes. The abundance of Turicibacter, Clostridium sensu stricto_1, and Romboutsia was reduced at the genus level. The differential microbiota is highly correlated with bile acid metabolism, which is speculated to be involved in ameliorating atherosclerotic lipid metabolism disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMethylaminesBile Acids and SaltsProbioticsBifidobacterium animalisAnimalsMiceGastrointestinal MicrobiomeMaleLipid MetabolismMice, Inbred C57BLHumans

Stichwörter der Autor:innen

Bif. animalis F1-3–2AtherosclerosisBile acidsLipid metabolismTMA-TMAO pathway

Substanzen

MethylaminesBile Acids and Saltstrimethyloxaminetrimethylamine

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao, 266100, Shandong, China.
  • College of Food Science and Engineering, Ocean University of China, Qingdao, 266003, Shandong, China.
  • College of Food Science and Engineering, Ocean University of China, Qingdao, 266003, Shandong, China. zhanglanwei@ouc.edu.cn.
  • Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao, 266100, Shandong, China. liangxi6029@163.com.

Förderung

  • Youth Program of Natural Science Foundation of Shandong province
  • Qingdao postdoctoral applied research project

Zitieren

APA

Zheng, X., Zhang, Z., Shan, T., Zhao, M., Lu, H., Zhang, L., & Liang, X. (2025). Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3–2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis. Probiotics and Antimicrobial Proteins, 17(6), 4851-4866. https://doi.org/10.1007/s12602-024-10417-x

Vancouver

Zheng X, Zhang Z, Shan T, Zhao M, Lu H, Zhang L, et al. Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3–2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis. Probiotics and Antimicrobial Proteins. 2025;17(6):4851-4866. doi:10.1007/s12602-024-10417-x

BibTeX
@article{Zheng2025,
  author = {Zheng, Xiumei and Zhang, Zhe and Shan, Tianhu and Zhao, Maozhen and Lu, Haiyan and Zhang, Lanwei and Liang, Xi},
  title = {Study on the Mechanism of Bifidobacterium animalis subsp. lactis F1-3–2 Regulating Bile Acid Metabolism Through TMA-TMAO Pathway to Improve Atherosclerosis},
  journal = {Probiotics and Antimicrobial Proteins},
  year = {2025},
  volume = {17},
  number = {6},
  pages = {4851--4866},
  doi = {10.1007/s12602-024-10417-x}
}
Kostenlos starten →